Introduction Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Introduction Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Discussion Erlotinib and gefitinib are orally bioavailable, synthetic anilinoquinazolines that
selectively and reversibly bind to the intracellular ATP-binding site of EGFR tyrosine kinase …

Introduction: Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Introduction: Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Introduction: Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Introduction Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …

Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains
unclear whether the hepatotoxicity induced by one compound is affected by the other. The …

Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains
unclear whether the hepatotoxicity induced by one compound is affected by the other. The …

Introduction: Gefitinib and erlotinib have minor differences in their chemical structures, and
thus it remains unclear whether the hepatotoxicity induced by one compound is affected by …